The Effect of Interferon Beta and Natalizumab on miR-20b Expression in Patients with Relapsing-Remitting Multiple Sclerosis is Potentially Mediated by Modulation of the Jak-STAT Signaling Pathway: A Case-control Study.
Aysan Jafari HarandiAlireza Mirzaee SedighMitra AtaeiSepideh BayramiEmran EsmaeilzadehMohammad Hossein SanatiPublished in: Iranian journal of immunology : IJI (2024)
Our findings suggest that the positive effects of IFN-β and NTZ in the RRMS patients could be potentially mediated by returning miR-20b expression to baseline.